Insights

Innovative Medical Solutions Northfield specializes in developing hemoglobin-based oxygen carriers, offering a groundbreaking alternative to traditional blood transfusions. This positions the company as a key player in emergency healthcare, trauma, and military applications where rapid, blood-type-independent oxygen delivery is critical.

Market Growth Potential With recent positive financial performance and increased investor interest indicated by stock performance and institutional investments, Northfield is demonstrating solid market traction. This growth momentum suggests opportunities for partnerships, co-development, and expansion into related healthcare markets.

Strategic Funding Environment Despite limited public funding data, recent investments from firms like Campbell & Co and others signal strong external financial backing, which can be leveraged to accelerate product development, regulatory approval processes, and market entry strategies for sales expansion.

Technological Capabilities Northfield's utilization of advanced tech stacks such as OpenResty, Nginx, and Google Analytics indicates a focus on data-driven research and development, creating opportunities to collaborate on innovative biotech solutions, digital health tools, or supply chain optimizations.

Healthcare Industry Focus The company's targeting of life-saving hemoglobin solutions aligns well with healthcare providers, hospitals, and emergency services sectors looking for reliable blood substitutes. Exploring strategic partnerships or pilot programs with these entities could open new sales channels for Northfield products.

Similar companies to Northfield

Northfield Tech Stack

Northfield uses 5 technology products and services including Cufon, Lua, Google Analytics, and more. Explore Northfield's tech stack below.

  • Cufon
    Font Scripts
  • Lua
    Programming Languages
  • Google Analytics
    Web Analytics
  • OpenResty
    Web Servers
  • Nginx
    Web Servers

Media & News

Northfield's Email Address Formats

Northfield uses at least 1 format(s):
Northfield Email FormatsExamplePercentage
FLast@northfieldlabs.comJDoe@northfieldlabs.com
50%
FLast@northfieldlabs.comJDoe@northfieldlabs.com
50%

Frequently Asked Questions

What is Northfield's stock symbol?

Minus sign iconPlus sign icon
Northfield is a publicly traded company; the company's stock symbol is NFBK.

What is Northfield's official website and social media links?

Minus sign iconPlus sign icon
Northfield's official website is northfieldlabs.com and has social profiles on LinkedIn.

What is Northfield's SIC code NAICS code?

Minus sign iconPlus sign icon
Northfield's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Northfield have currently?

Minus sign iconPlus sign icon
As of December 2025, Northfield has approximately 92 employees across 4 continents, including North AmericaAsiaEurope. Key team members include President: L. D.President: M. K.Partner: N. C.. Explore Northfield's employee directory with LeadIQ.

What industry does Northfield belong to?

Minus sign iconPlus sign icon
Northfield operates in the Biotechnology Research industry.

What technology does Northfield use?

Minus sign iconPlus sign icon
Northfield's tech stack includes CufonLuaGoogle AnalyticsOpenRestyNginx.

What is Northfield's email format?

Minus sign iconPlus sign icon
Northfield's email format typically follows the pattern of FLast@northfieldlabs.com. Find more Northfield email formats with LeadIQ.

When was Northfield founded?

Minus sign iconPlus sign icon
Northfield was founded in 1994.

Northfield

Biotechnology ResearchUnited States51-200 Employees

We are a leader in developing a hemoglobin-based oxygen-carrying red blood cell substitute. The initial indication we are seeking for our product PolyHeme® is the treatment of life-threatening hemoglobin levels when blood transfusion is indicated but red blood cells may not be available, appropriate or acceptable. PolyHeme® is a solution of chemically modified human hemoglobin that requires no cross-matching and is therefore compatible with all blood types. It has an extended shelf life in excess of 12 months.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
NFBK
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1994
Employees
51-200

Section iconFunding & Financials

  • $100M$250M

    Northfield's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $100M$250M

    Northfield's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.